7. Diabetes Technology: Standards of Care in Diabetes—2023
NA ElSayed, G Aleppo, VR Aroda, RR Bannuru… - Diabetes …, 2023 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …
ADA's current clinical practice recommendations and is intended to provide the components …
Continuous glucose monitoring and metrics for clinical trials: an international consensus statement
T Battelino, CM Alexander, SA Amiel… - The lancet Diabetes & …, 2023 - thelancet.com
Randomised controlled trials and other prospective clinical studies for novel medical
interventions in people with diabetes have traditionally reported HbA 1c as the measure of …
interventions in people with diabetes have traditionally reported HbA 1c as the measure of …
American Association of Clinical Endocrinology clinical practice guideline: developing a diabetes mellitus comprehensive care plan—2022 update
L Blonde, GE Umpierrez, SS Reddy, JB McGill… - Endocrine Practice, 2022 - Elsevier
Objective The objective of this clinical practice guideline is to provide updated and new
evidence-based recommendations for the comprehensive care of persons with diabetes …
evidence-based recommendations for the comprehensive care of persons with diabetes …
Heart failure: an underappreciated complication of diabetes. A consensus report of the American Diabetes Association
R Pop-Busui, JL Januzzi, D Bruemmer… - Diabetes …, 2022 - Am Diabetes Assoc
Heart failure (HF) has been recognized as a common complication of diabetes, with a
prevalence of up to 22% in individuals with diabetes and increasing incidence rates. Data …
prevalence of up to 22% in individuals with diabetes and increasing incidence rates. Data …
Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study …
MJ Davies, VR Aroda, BS Collins, RA Gabbay… - Diabetes …, 2022 - Am Diabetes Assoc
The American Diabetes Association and the European Association for the Study of Diabetes
convened a panel to update the previous consensus statements on the management of …
convened a panel to update the previous consensus statements on the management of …
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the …
Abstract The American Diabetes Association and the European Association for the Study of
Diabetes convened a panel to update the previous consensus statements on the …
Diabetes convened a panel to update the previous consensus statements on the …
Digital technology for diabetes
MS Hughes, A Addala… - New England Journal of …, 2023 - Mass Medical Soc
Digital Technology for Diabetes | NEJM Skip to main content NEJM Group Follow Us Facebook
Twitter Instagram YouTube LinkedIn Prepare to become a physician, build your knowledge …
Twitter Instagram YouTube LinkedIn Prepare to become a physician, build your knowledge …
Glycaemic management in diabetes: old and new approaches
HbA 1c is the most used parameter to assess glycaemic control. However, evidence
suggests that the concept of hyperglycaemia has profoundly changed and that different …
suggests that the concept of hyperglycaemia has profoundly changed and that different …
Wearable devices in cardiovascular medicine
Wearable devices, such as smartwatches and activity trackers, are commonly used by
patients in their everyday lives to manage their health and well-being. These devices collect …
patients in their everyday lives to manage their health and well-being. These devices collect …
[HTML][HTML] Hypoglycemia in diabetes: An update on pathophysiology, treatment, and prevention
A Nakhleh, N Shehadeh - World journal of diabetes, 2021 - ncbi.nlm.nih.gov
Hypoglycemia is a common complication in patients with diabetes, mainly in those treated
with insulin, sulfonylurea, or glinide. Impairments in counterregulatory responses and …
with insulin, sulfonylurea, or glinide. Impairments in counterregulatory responses and …